您的购物车当前为空
别名 RTI-13951-33 hydrochloride (2244884-08-8 free base)
RTI-13951-33 hydrochloride 是一种有效的、选择性的、可透过血脑屏障的GPR88激动剂。RTI-13951-33 hydrochloride 在 GPR88 cAMP 功能性测定中,EC50值为 25 nM。RTI-13951-33 hydrochloride 可以降低大鼠酒精强化和摄入行为。

RTI-13951-33 hydrochloride 是一种有效的、选择性的、可透过血脑屏障的GPR88激动剂。RTI-13951-33 hydrochloride 在 GPR88 cAMP 功能性测定中,EC50值为 25 nM。RTI-13951-33 hydrochloride 可以降低大鼠酒精强化和摄入行为。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | 待询 | 3-6月 | |
| 50 mg | 待询 | 3-6月 | |
| 100 mg | 待询 | 3-6月 |
| 产品描述 | RTI-13951-33 hydrochloride is a potent, selective, and brain-penetrant GPR88 agonist. RTI-13951-33 hydrochloride exhibited an EC 50 of 25 nM in vitro cAMP functional assay. RTI-13951-33 hydrochloride significantly reduces alcohol reinforcement and intake behaviors in rats [1]. |
| 靶点活性 | GPR88:(EC50)25 nM |
| 体外活性 | RTI-13951-33 is a potent, selective, and brain-penetrant GPR88 agonist, with an EC 50 of 25 nM in GPR88 cAMP functional assay. RTI-13951-33 elevates [ 35 S]-GTPγS binding (EC 50, 535 nM) in mouse striatal membranes however not in membranes from GPR88 KO mice [1]. RTI-13951-33 has weak affinities at kappa opioid receptor (KOR; K i, 2.29 μM), vesicular monoamine transporter (VMAT; K i, 4.23 μM), and moderate affinity at serotonin transporter (SERT; K i, 0.75 μM) but RTI-13951-33 poorly inhibits SERT (IC 50, 25.1±2.7 μM) [1]. |
| 体内活性 | RTI-13951-33 (10 and 20 mg/kg, i.p.) decreases alcohol lever responses in a rat model of alcohol self-administration in a dose-dependent manner [1]. RTI-13951-33 (10 mg/kg, i.p.) shows sufficient brain penetration, with t 1/2 of 48 min and 87 min in rat plasma and brain [1]. |
| 别名 | RTI-13951-33 hydrochloride (2244884-08-8 free base) |
| 分子量 | 532.5 |
| 分子式 | C28H35Cl2N3O3 |
| Smiles | COCC1=CC=C(C2=CC=C(N(C[C@@H](N)[C@@H](C)OC)C([C@H]3[C@H](C4=CC=CC=N4)C3)=O)C=C2)C=C1.Cl.Cl |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 125 mg/mL (234.74 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (6.2 mM), Sonication is recommeded. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多